12 Best Growth Stocks Under $25 to Buy Now

9. ADMA Biologics, Inc. (NASDAQ:ADMA)

Number of Hedge Fund Holders: 25

Share Price as of January 8, 2024: $18.29

ADMA Biologics, Inc. (NASDAQ:ADMA) ranks ninth on our list of the best growth stocks under $25 to buy now. The biotechnology company is an end-to-end biopharmaceutical company that is driving the launch of plasma-based products using immunotechnology. So far the company has 3 FDA-approved products, aligning with its goal of commercializing specialty biologics for the treatment of infectious diseases and immune-compromised patients.

As a result of its commercialization, in the third quarter of 2024, ADMA Biologics, Inc. (NASDAQ:ADMA) logged revenue worth $119.8 million, up by 78% year-over-year. Net income during the same quarter reached $35.9 million, a whopping 1,300% increase from the same period in 2023. Consequently, the company raised its full-year guidance for revenue and net income, emphasizing its sound financial position.

The company has also strengthened its governance over time, contributing to its position on our list and as a favorite among investors. Recently the company onboarded and partnered with KPMG as a registered public accounting firm. This emphasizes the company’s growing financial position and market value.